SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Rezera Aims to Raise Up to $217 Million in U.S. IPO

Drug developer Rezera said it aims to raise up to $217 million in a U.S. IPO.

Related stories